Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-07-28
1996-05-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 26, 514 56, 514 59, 514159, 514165, 514169, 514177, 514458, 514728, A61K 31715
Patent
active
055146678
ABSTRACT:
A method for the topical treatment of herpes virus infections of the skin and mucous membranes is disclosed- This method uses a topical preparation comprising an anti-vital drug in combination with a potentiating drug which is an anti-inflammatory or an anti-oxidant drug. A preferred preparation includes zinc pentosan polysulphate in combination with bufexamac.
REFERENCES:
patent: 4900815 (1990-02-01), Tanaka et al.
patent: 5055301 (1991-10-01), Voigt et al.
patent: 5055457 (1991-10-01), Schrinner et al.
patent: 5100879 (1992-03-01), Ueno et al.
patent: 5145841 (1992-09-01), Cullis-Hill et al.
patent: 5153181 (1992-10-01), Diringer et al.
patent: 5158940 (1992-10-01), LaRocca et al.
"Principles of Medicinal Chemistry", third edition, W. O. Foye, ed., Lea and Febiger, Philadelphia, 1989, Chapter 23.
Kobayashi et al; Tokushima J. Exp. Med. 26:41-51 (1979).
Yamashita et al; Dev. Oncor. 4 (Metasis):127-131 (1980).
Maat et al; J. Cancer Res. Clin. Oncol. 101:275-283 (1981).
Folkman et al; Science 221:719-725 (1983).
Gorelik et al; Int. J. Cancer 33:87-94 (1984).
Milas et al; Clin. Expl. Metastasis 3(4):247-255 (1985).
Spruance et al; Antmicrob. Agents Chemother. 30(1):196-B (Jul. 1986).
Goodman and Gilman's 7th Ed. pp. 1471-1472 2nd 594.
The Merck Manual 15th ed. (1987) pp. 158-171, 180-1.
Sakamoto et al; Invasion Metastasis 7:208-216 (1987).
Gorelik; Cancer Res. 47:809-815 (Feb. 1987).
Coombe et al; Int. J. Cancer 39(1):82-88 (1987).
Nakashima et al; JPN. J. Cancer Res. 78:1164-1168 (1987).
Van Gendersen et al; Chem. AB. 108:15849f (1988).
Kristofferson et al; J. Gen. Virol. 69(6):1157.1166 (1988).
Yamamoto et al; Chem. AB 111:167383z (1989).
Oeberg: Chem. AB. 110:878032 (1989).
Ito et al; Eur. J. Clin. Microbiol. Infect. Dis. 8:171-173 (1989).
Folkman et al; Science 243:1490-1493 (1989).
Dillman et al; Mol. Brother. 4:117-121 (1992).
Parish et al "Evidence that Sulphated . . . " Int. J. Cancer 40:511-8 (1987).
Baba et al "Sulphated Polysaccharides Are . . . " Antmicrob. Agents Chemother. 32:1742-5 (1988).
Czekelius--Abstract, p. 79 I. Abt. Orig. A217 (1971):300-325.
Schramm-Thiel et al--Abstract, p. 79 Arzneim.-Forsch.21(a) (1971):1389-1392.
Raff et al--Abstract pp. 79-80.
Munch. Med. WSCHR. 119 Nr. 25 (1977):817-818.
Arthropharm PTY. Limited
Fonda Kathleen Kahler
Robinson Douglas W.
LandOfFree
Method for topical treatment of herpes infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for topical treatment of herpes infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for topical treatment of herpes infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227325